BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6889732)

  • 21. Tumors of serosal tissue origin.
    Bolen JW
    Clin Lab Med; 1987 Mar; 7(1):31-50. PubMed ID: 3549129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thoracoscopy in pleural mesothelioma. Diagnostic, prognostic and therapeutic interest (author's transl)].
    Boutin C; Farisse P; Viallat JR; Cargnino P; Choux R
    Rev Fr Mal Respir; 1979 Dec; 7(7):680-6. PubMed ID: 555011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pleural sarcomatoid malignant mesothelioma consisting of histiocytoid cells.
    Kawahara K; Nagano T; Matsui K; Kawai T; Iwasaki T
    Pathol Int; 2007 Apr; 57(4):229-31. PubMed ID: 17316420
    [No Abstract]   [Full Text] [Related]  

  • 24. On the ultrastructural discrimination between mesothelial and tumour cells in pleural cavity effusions (study on the nucleus).
    Valkov I; Topov J; Vassilev N
    Patol Pol; 1979; 30(4):567-74. PubMed ID: 542357
    [No Abstract]   [Full Text] [Related]  

  • 25. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.
    Cury PM; Butcher DN; Corrin B; Nicholson AG
    J Pathol; 1999 Oct; 189(2):251-7. PubMed ID: 10547583
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cytology of malignant mesothelioma in Western Australia.
    Whitaker D; Shilkin KB
    Acta Cytol; 1978; 22(2):67-70. PubMed ID: 276234
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The ultrastructural pathology of malignant pleural mesothelioma.
    Coleman M; Henderson DW; Mukherjee TM
    Pathol Annu; 1989; 24 Pt 1():303-53. PubMed ID: 2654842
    [No Abstract]   [Full Text] [Related]  

  • 28. Diagnostic significance of carcinoembryonic antigen in the differential diagnosis of malignant mesothelioma.
    Mezger J; Lamerz R; Permanetter W
    J Thorac Cardiovasc Surg; 1990 Dec; 100(6):860-6. PubMed ID: 2147220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary nonspecific chronic pleurisy (author's transl)].
    Knolle H; Heinicke G; Matzel W
    Arch Geschwulstforsch; 1977; 47(3):210-9. PubMed ID: 907442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Freeze-fracture study of intercellular junctions in benign and malignant mesothelial cells in effusions and a comparison with those seen in pleural mesotheliomas (solid tumour).
    Mukherjee TM; Swift JG; Henderson DW
    J Submicrosc Cytol Pathol; 1988 Jan; 20(1):195-208. PubMed ID: 3370618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of claudin-4 immunostaining in the diagnosis of mesothelioma.
    Ordóñez NG
    Am J Clin Pathol; 2013 May; 139(5):611-9. PubMed ID: 23596113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathology of malignant mesothelioma.
    Van Marck E
    Lung Cancer; 2004 Aug; 45 Suppl 1():S35-6. PubMed ID: 15261431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benign and malignant pleural mesothelioma.
    Antman KH; Corson JM
    Clin Chest Med; 1985 Mar; 6(1):127-40. PubMed ID: 3891207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Malignant mesothelioma of the pleura--diagnostic difficulties].
    Drozdowska A; Damps-Konstańska I; Kobierska-Gulida G; Madrzak J; Kuziemski K; Pieńkowska J; Ucińska R; Słomiński JM
    Pol Merkur Lekarski; 2004 Oct; 17(100):380-1. PubMed ID: 15690708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pleural multicystic mesothelial proliferation: a mimicker of benign peritoneal mesothelioma.
    Agarwal S; Mullick S; Gupta K; Prasad S
    Indian J Pathol Microbiol; 2013; 56(4):476-7. PubMed ID: 24441257
    [No Abstract]   [Full Text] [Related]  

  • 37. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scoring system for differential diagnosis of malignant mesothelioma and reactive mesothelial cells on cytology specimens.
    Kimura N; Dota K; Araya Y; Ishidate T; Ishizaka M
    Diagn Cytopathol; 2009 Dec; 37(12):885-90. PubMed ID: 19572412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Morphological diagnostics of malignant pleural mesothelioma].
    Junker K; Müller KM
    Pathologe; 2014 Nov; 35(6):586-90. PubMed ID: 25304423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of pleural malignant mesothelioma in life--a practical approach.
    Whitaker D; Shilkin KB
    J Pathol; 1984 Jul; 143(3):147-75. PubMed ID: 6379132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.